In this Issue
As clinical experience grows, progress continues in a variety of challenging scenarios.
Chief Medical Editor’s Page
By Takao Ohki, MD, PhD
A status report on thoracic endovascular aortic repair.
By Frank J. Criado, MD, FACS, FSVM
An overview of technological improvements that may be expected in the next generation of thoracic endovascular devices.
By W. Anthony Lee, MD, FACS
An alternative method for treating complex aortic emergencies in patients who are unfit for surgery.
By Joseph J. Ricotta II, MD, MS, and Nikolaos Tsilimparis, MD
The emergence of endovascular therapy in this challenging anatomy as an alternative to open repair.
By Matt Thompson, MD, FRCS
Determining if endovascular intervention is the best treatment option.
By Mark K. Eskandari, MD
Roy K. Greenberg, MD, provides a look at five of the most important articles published in the thoracic endovascular repair field during the past year, summarizing each and offering commentary on their impact.
If you perform TEVAR to treat acute type B dissection, do you use IVUS during the procedure?
By Manish Mehta, MD; Ross Milner, MD; Michael D. Dake, MD; Edward Y. Woo, MD; and Firas F. Mussa, MD
Successful endovascular exclusion of an iliac artery pseudoaneurysm and ilio-iliac arteriovenous fistula sustained during laparoscopic hysterectomy.
By Grace J. Wang, MD, and Paul J. Foley, MD
How can we improve survival rates?
By Joshua A. Beckman, MD, MS
A preview of today’s new products
The Head of Diagnostic and Interventional Radiology at the Academic Hospital RoMed Clinic of Rosenheim in Germany discusses the recent CIRSE meeting, as well as the current study of drug-coated balloons for treating lower extremity disease.